AACR22: As post-Covid de­vel­op­ment takes shape, BioN­Tech re­ports first hu­man da­ta for CAR-T/can­cer vac­cine com­bo

NEW OR­LEANS — Con­tin­u­ing to push in­to new fron­tiers fol­low­ing the huge suc­cess of its Covid-19 vac­cine, BioN­Tech re­vealed the first-in-hu­man da­ta for its com­bi­na­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA